{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:34:59Z","timestamp":1786653299965,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oman J Ophthalmol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0974-620x.169896","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T05:57:36Z","timestamp":1447912656000},"page":"166","source":"Crossref","is-referenced-by-count":1,"title":["Experience of intravitreal injections in a tertiary Hospital in Oman"],"prefix":"10.4103","volume":"8","author":[{"given":"AhmedS","family":"Al-Hinai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-620X.169896-1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: A comprehensive review","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"key-10.4103\/0974-620X.169896-2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/eye.2008.55","article-title":"Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy","author":"Huang","year":"2009","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0974-620X.169896-3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000224782","article-title":"Intravitreal bevacizumab to treat acute central serous chorioretinopathy: Short-term effect","author":"Seong","year":"2009","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0974-620X.169896-4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IAE.0b013e3181bcf0b4","article-title":"Intravitreal bevacizumab injection for central serous chorioretinopathy","author":"Lim","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/0974-620X.169896-5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3129\/i08-069","article-title":"Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis","author":"Windisch","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-6","first-page":"941","article-title":"Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia","author":"Charbel","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-7","first-page":"1357","article-title":"Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia","author":"Rouvas","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00417-013-2433-1","article-title":"Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy","author":"Saito","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/112067210801800427","article-title":"Short-term anatomic effect of ranibizumab for polypoidal choroidal vasculopathy","author":"Reche-Frutos","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/IAE.0b013e3181f274ec","article-title":"Photodynamic therapy, ranibizumab, and ranibizumab with photodynamic therapy for the treatment of polypoidal choroidal vasculopathy","author":"Rouvas","year":"2011","journal-title":"Retina"},{"key":"key-10.4103\/0974-620X.169896-11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ajo.2013.05.038","article-title":"Long-term visual outcome and prognostic factors after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy","author":"Kang","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/eye.2011.149","article-title":"Bevacizumab prior to vitrectomy for diabetic traction retinal detachment","author":"Pokroy","year":"2011","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0974-620X.169896-13","first-page":"81","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): Results of the Pan-American Collaborative Retina Study Group (PACORES)","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/OPTH.S11094","article-title":"Intravitreal injection analysis at the Bascom Palmer Eye Institute: Evaluation of clinical indications for the treatment and incidence rates of endophthalmitis","author":"Cavalcante","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2012-302451","article-title":"Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema","author":"Zehetner","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bjo.2008.156810","article-title":"Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab","author":"Matsuyama","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-620X.169896-17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.09-4140","article-title":"Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes","author":"Miyake","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0974-620X.169896-18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/IAE.0b013e31825db6ba","article-title":"Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials","author":"Bressler","year":"2012","journal-title":"Retina"},{"key":"key-10.4103\/0974-620X.169896-19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/IAE.0b013e318276e07b","article-title":"Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: A whole population study","author":"Kemp","year":"2013","journal-title":"Retina"},{"key":"key-10.4103\/0974-620X.169896-20","first-page":"1388","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results","author":"Comparison","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.169896-21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.survophthal.2010.08.006","article-title":"Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease","author":"Tolentino","year":"2011","journal-title":"Surv Ophthalmol"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:01Z","timestamp":1786649701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-620X.169896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["169896"],"URL":"https:\/\/doi.org\/10.4103\/0974-620x.169896","relation":{},"ISSN":["0974-620X"],"issn-type":[{"value":"0974-620X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}